contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


dagens-aktienyheder-2105-mapspeople-curasight-vestjysk-bank-spar-nord-og-scandinavian-medical-solutions

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

MapsPeople is a Software-as-a-Service (SaaS) company focusing on digital mapping for indoor navigation. The two primary revenue streams are 1) MapsIndoors which is MapsPeople’s own developed mapping solution for indoor navigation 2) Google Maps partnership with Google. MapsIndoors is the key segment with high double-digit growth rates, and the Google Maps segment is expected to be a more steady business going forward.

MapsPeople has a global presence with offices in Denmark, Germany, Singapore and United States, and customers include some of the largest brands in the world. The company has been listed at Nasdaq First North Premier in Denmark since June 2021.

MapsPeople

Curasight is a Danish biotech company focusing on developing and improving the detection and treatment of cancer in a more gentle and efficient way. The company has two pipeline products that both use radionuclide (nuclear medicine) to facilitate better diagnosis and treatment of various cancer types; uTRACE use the so-called uPAR as a biomarker to diagnose the aggressiveness of cancer, and uTREAT use the uPAR as a attachment to treat the cancer.

Based on good phase 2 data that has already been collected or will be in the first half of 2022, Curasight is expected to prepare phase 3 for uTRACE later in 2022 and 2023 for the following four cancer types: prostate, brain, neuroendocrine, and head and neck cancer.

Curasight

Vestjysk Bank conducts banking operations. Today, the bank offers a wide range of financial services, including savings, financing and asset management, as well as pension insurance for both private and corporate customers. A large part of the customers is in the agricultural and marine sectors. The bank was originally founded in 1874 and is headquartered in Lemvig, Denmark.

Vestjysk Bank

Spar Nord Bank

Scandinavian Medical Solutions is a Danish-based trading company specialized in purchase and resale of used diagnostic imaging equipment such as CT scanners and MR scanners of high quality. Scandinavian Medical Solutions is specialized in offering flexible solutions for customers with specific demands, which is often a better and cheaper alternative to a new and more expensive produced OEM-equipment.

Scandinavian Medical Solutions was founded in 2018, and the company has been listed at Nasdaq First North in Denmark since November 2021.

Scandinavian Medical Solutions

Dagens aktienyheder med MapsPeople, Curasight, Vestjysk Bank, Spar Nord og Scandinavian Medical Solutions

MapsPeople er her til morgen ude med regnskabet for f&#xf8;rste kvartal af 2025. Selskabets ARR voksede 12% YoY til DKK 59,8 mio. ved udgangen af Q1 2025. Det var en kvartalsvis stigning p&#xe5; 3% sammenlignet med slutningen af Q4 2024. EBITDA f&#xf8;r engangsposter blev i Q1 2025 forbedret til DKK -6,95 mio. (DKK -8,53 mio. i Q1 2024). Her til eftermiddag kl. 14:00 kan du m&#xf8;de og stille sp&#xf8;rgsm&#xe5;l til MapsPeoples ledelse, der vil pr&#xe6;sentere de seneste resultater og svare p&#xe5; sp&#xf8;rgsm&#xe5;l, herunder p&#xe5; den forventede afnotering efter salg af minimum 51% af aktierne til Apex Group Technologies. Tilmeld dig og stil dine sp&#xf8;rgsm&#xe5;l her: <a href="https://www.inderes.dk/videos/mapspeople-presentation-of-q1-2025-report">https://www.inderes.dk/videos/mapspeople-presentation-of-q1-2025-report</a>
Curasight annoncerer det endelige udfald af kapitalforh&#xf8;jelsen. Baseret p&#xe5; resultatet vil Curasight modtage cirka DKK 47 mio. fra fortegningsemissionen f&#xf8;r emissionsomkostninger og tilbagebetaling af brofinansieringsl&#xe5;net til Fenja Capital II A/S. L&#xe6;s mere her:&#xa0;<a class="x1i10hfl xjbqb8w x1ejq31n xd10rxx x1sy0etr x17r0tee x972fbf xcfux6l x1qhh985 xm0m39n x9f619 x1ypdohk xt0psk2 xe8uvvx xdj266r x11i5rnm xat24cr x1mh8g0r xexx8yu x4uap5 x18d9i69 xkhd6sd x16tdsg8 xggy1nq x1a2a7pz x1s688f x1heor9g x1bvjpef xujl8zx" tabindex="0" role="link" href="https://www.inderes.dk/analyst-comments/curasight-endeligt-udfald-af-kapitalforhojelsen?fbclid=IwZXh0bgNhZW0CMTAAYnJpZBExUk9XcFY0OVFGcEl3bWtGZgEeRuuWtTzrtd0_sRaKeEAI0R8CkbWI3l1taMowpNruBfL7duqGxqOTC5U09qo_aem_IBFQXNZGZ6ixXz3D-lplBw" target="_blank" rel="nofollow noopener noreferrer">https://www.inderes.dk/analyst-comments/curasight-endeligt-udfald-af-kapitalforhojelsen</a>
Vestjysk Bank offentliggjorde i g&#xe5;r eftermiddags sit regnskab for 1. kvartal 2025, der som ventet viser en vigende bundlinje, som vi har set det hos de fleste banker, prim&#xe6;rt som f&#xf8;lge af lavere nettorenteindt&#xe6;gter. Vestjysk Bank fastholder forventningerne til hele 2025. L&#xe6;s hele vores kommentar her: <a class="x1i10hfl xjbqb8w x1ejq31n xd10rxx x1sy0etr x17r0tee x972fbf xcfux6l x1qhh985 xm0m39n x9f619 x1ypdohk xt0psk2 xe8uvvx xdj266r x11i5rnm xat24cr x1mh8g0r xexx8yu x4uap5 x18d9i69 xkhd6sd x16tdsg8 xggy1nq x1a2a7pz x1s688f x1heor9g x1bvjpef xujl8zx" tabindex="-1" role="link" href="https://www.inderes.dk/analyst-comments/vestjysk-bank-regnskab-for-1-kvartal-2025?fbclid=IwZXh0bgNhZW0CMTAAYnJpZBExUk9XcFY0OVFGcEl3bWtGZgEeNLIh6XxV4qpE3nRJKMu1b1TpeBRFcN1E0TRAlwptmH8B2ZZGhVEp7AIXREc_aem_lmdOysLm0GZC0YTd_mBBmg" target="_blank" rel="nofollow noopener noreferrer">https://www.inderes.dk/analyst-comments/vestjysk-bank-regnskab-for-1-kvartal-2025</a>
Nykredit meddelte i g&#xe5;r, at man har modtaget alle de regulatoriske myndighedsgodkendelser hvoraf den sidste var fra Konkurrence- og Forbrugerstyrelsen, og som har v&#xe6;ret &#xe5;rsag til en r&#xe6;kke forl&#xe6;ngelser af tilbuddet til Spar Nord aktion&#xe6;rerne. Nykredit ventes senere i dag at offentligg&#xf8;re en forel&#xf8;big opg&#xf8;relse af antal accepter og om tilbuddet afsluttes. If&#xf8;lge en tidligere melding havde Nykredit kendskab til at 2/3 af aktion&#xe6;rerne i Spar Nord havde accepteret tilbuddet.
Scandinavian Medical Solutions annoncerede i g&#xe5;r et st&#xf8;rre salg af en PET/CT-scanner til en v&#xe6;rdi p&#xe5; mellem DKK 2,0 mio. til under DKK 3,5 mio. L&#xe6;s mere her og f&#xe5; et indblik over annoncerede ordrer til markedet sammenlignet med sidste &#xe5;r: <a href="https://www.inderes.dk/analyst-comments/scandinavian-medical-solutions-fjerde-storre-salg-af-petct-scanner-i-dette-regnskabsar">https://www.inderes.dk/analyst-comments/scandinavian-medical-solutions-fjerde-storre-salg-af-petct-scanner-i-dette-regnskabsar</a>
Disclaimer: HC Andersen Capital modtager betaling fra de n&#xe6;vnte selskaber for en digital IR abonnementsaftale.
/Kasper Lihn, d. 21/05-2025 kl. 09:07.

Dagens aktienyheder 21/05: MapsPeople, Curasight, Vestjysk Bank, Spar Nord og Scandinavian Medical Solutions

Stay up to date